Stock NRSN NEUROSENSE THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart NeuroSense Therapeutics Ltd.

Equities

NRSN

IL0011809592

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
1.08 USD -.--% Intraday chart for NeuroSense Therapeutics Ltd. -7.46% +37.58%
May. 14 NeuroSense Partners with PhaseV for ALS Treatment Trial -- Shares Up MT
May. 07 NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NEUROSENSE THERAPEUTICS LTD.
Bio Therapeutic Drugs
-.--%-7.46%+37.58%-30.77% - 19.48M
Bearish
Neutral
Bullish
  1. Stock Market
  2. Equities
  3. NRSN Stock
  4. Charts NeuroSense Therapeutics Ltd.
  5. Relative Strength Chart